Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
A complex ecosystem formed by the microorganisms that reside within human organs is gastrointestinal tract, urogenital
tract, skin and nasal and oral mucosa. Albeit, largest pool of microbiome in the human body is gastrointestinal tract that
comprising 99% anaerobic bacteria and remaining are fungi, protozoan and archaebacteria. The ratio of prokaryotic microbial
cells within the human body to eukaryotic human cells is 100:1 and gene ratio is 150:1. Recently, it has been identified that
Microbiome resides in human predict four major division of bacterium resides in GI tract namely actinobacteria (3%),
bacteroidetes (23%), firmicutes (64%) and proteobacteria (8%). Remainder 2% consists of diverse minor taxonomic division.
Further, such kind of microbial cells has been found to involve in the progression of neurodegenerative disorders. Alzheimer�s
disease is one of the most lethal disorders which befalls several damages in the brain due to accumulation of toxic Amyloid
Beta (A�²), directed by mainly dementia, cognitive disabilities and tauopathy. Interestingly, amyloid is secreted by various
species of microbiome including bacteria and fungi. Blood examination of AD patients has also revealed through the presence
of disperse Mycoses and amyloidogenic fungal protein which was found to link with increased risk of AD due to chronic fungal
infection. Molecular mimicry is another factor underlying mechanism for neurodegeneration through bacterial amyloid. In
spite of this, many plant and animal viruses are also associated with molecular mimicry and altered protein expression in AD.
Based on this ground, we demonstrated the microbial source of amyloid causing AD, illustrated underlying mechanism of AD
due to microbial amyloid, elucidated the amyloid protein interaction with other proteins and finally, analyzed the microbial
product for AD treatment using in silico techniques.